INCY
Incyte Corp
Price:  
60.33 
USD
Volume:  
1,960,426.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Incyte EV/EBITDA

-0.2%
Upside

As of 2024-02-22, the EV/EBITDA ratio of Incyte Corp (INCY) is 13.45. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Incyte's latest enterprise value is 10,325.26 mil USD. Incyte's TTM EBITDA according to its financial statements is 767.70 mil USD. Dividing these 2 quantities gives us the above Incyte EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 11.5x - 13.5x 13.4x
Forward P/E multiples 11.0x - 13.6x 12.5x
Fair Price 53.58 - 64.24 60.21
Upside -11.2% - 6.5% -0.2%
60.33 USD
Stock Price
60.21 USD
Fair Price

Incyte EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-21 31.81
2024-02-20 31.02
2024-02-16 30.56
2024-02-15 31.10
2024-02-14 30.53
2024-02-13 31.29
2024-02-12 30.50
2024-02-09 30.41
2024-02-08 30.25
2024-02-07 30.24
2024-02-06 31.44
2024-02-05 30.62
2024-02-02 30.77
2024-02-01 31.20
2024-01-31 30.99
2024-01-30 31.26
2024-01-29 31.89
2024-01-26 31.98
2024-01-25 32.12
2024-01-24 32.08
2024-01-23 32.63
2024-01-22 32.43
2024-01-19 32.42
2024-01-18 32.26
2024-01-17 32.42
2024-01-16 32.35
2024-01-12 33.08
2024-01-11 33.28
2024-01-10 33.82
2024-01-09 33.95
2024-01-08 34.71
2024-01-05 34.41
2024-01-04 35.11
2024-01-03 34.54
2024-01-02 34.51
2023-12-29 33.11
2023-12-28 33.08
2023-12-27 33.05
2023-12-26 32.98
2023-12-22 33.14
2023-12-21 32.53
2023-12-20 32.04
2023-12-19 32.64
2023-12-18 31.97
2023-12-15 32.85
2023-12-14 33.66
2023-12-13 33.85
2023-12-12 32.62
2023-12-11 30.08
2023-12-08 28.84